Advertisement

Resectable Esophageal Carcinoma: Preoperative Versus Postoperative Radiochemotherapy

  • Hiroshi Matsuura
  • Kenji Suzuki
  • Tsukasa Kotoh
  • Hiroshi Yoshimura
  • Shunichi Abe
  • Teruhisa Nakamura
Conference paper

Abstract

It is generally accepted that chemotherapy and radiotherapy for esophageal carcinoma provide significant palliation, and multiple modality therapy has become the common trend during the past two decades [1, 2]. Surgery continues to be the cornerstone of treatment, and most protocols consist of surgical therapy combined with these adjuvant therapies. Preoperative radiation therapy was introduced in the 1960s and is still in use with promising results [3, 4]. However, there are several reports indicating that preoperative therapy neither improves the resectability nor the survival rate of patients who undergo resection [5, 6].

Keywords

Herpes Zoster Esophageal Carcinoma Preoperative Therapy Esophageal Disease Serum Glutamic Pyruvic Transaminase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stewart FM, Harkins BJ, Hahn SS, Daniel TM (1989) Cisplatin, 5-Fluorouracil, Mitomycin C, and concurrent radiation therapy with and without esophagectomy for esophageal carcinoma. Cancer 64: 622–628PubMedCrossRefGoogle Scholar
  2. 2.
    Kelsen D (1982) Treatment of advanced esophageal cancer. Cancer 50: 2576–2581PubMedGoogle Scholar
  3. 3.
    Clifton EE, Goodner JT, Bronstein EL (1960) Preoperative irradiation for cancer of the esophagus. Cancer 13: 37–45CrossRefGoogle Scholar
  4. 4.
    Sugimachi K, Matsufuji H, Kai H, Matsuda H, Ueo H, Inokuchi K (1986) Preoperative irradiation for carcinoma of the esophagus. Surg Gynecol Obstet 162: 174–176PubMedGoogle Scholar
  5. 5.
    Eortc (1985) Preoperative radiotherapy for carcinoma of the esophagus: Results of a prospective multicenter study. In: DeMeester TR, Skinner DB (eds) Esophageal disorders: Pathophysiology and therapy. Raven, New York, pp 367–371Google Scholar
  6. 6.
    Iizuka T, Ide H, Kakegawa T, Sasaki K, Takagi I, Ando N, Mori S, Arimori M, Tsugane S (1988) Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 93: 1054–1058PubMedCrossRefGoogle Scholar
  7. 7.
    Japanese Society of Esophageal Diseases (1976) Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 6: 1–39CrossRefGoogle Scholar
  8. 8.
    Tsutsui S, Morita M, Kuwano H, Matsuda H, Mori M, Okamura S, Sugimachi K (1992) Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma. J Surg Oncol 49: 176–181PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Hiroshi Matsuura
  • Kenji Suzuki
  • Tsukasa Kotoh
  • Hiroshi Yoshimura
  • Shunichi Abe
  • Teruhisa Nakamura
    • 1
  1. 1.Department of Surgery IIShimane Medical UniversityIzumo, Shimane, 693Japan

Personalised recommendations